VCYT Key Stats
- VERACYTE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events Yahoo 03/07 16:43 ET
- Nasdaq stocks posting largest percentage increases AP 03/07 13:23 ET
- Can Veracyte (VCYT) Continue to Rise? - Tale of the Tape Zacks 03/07 10:02 ET
- Can Veracyte (VCYT) Continue to Rise? Yahoo 03/07 09:03 ET
- Veracyte Updates Presentation Date and Time at the Cowen and Company 34th Annual Health Care Conference noodls 03/03 15:25 ET
- 1:29 pm Veracyte updates presentation date and time at the Cowen and Company 34th Annual Health Care Conference; presentation and webcast scheduled for Tuesday, March 4, at 8am ET Yahoo 03/03 13:29 ET
- Veracyte to Present at Cowen and Company 34th Annual Health Care Conference noodls 02/26 10:02 ET
- VERACYTE, INC. Files SEC form 8-K, Change in Directors or Principal Officers Yahoo 02/25 16:11 ET
- Veracyte To Present At 2014 Leerink Global Healthcare Conference noodls 02/05 07:38 ET
- [$$] Female CEOs Missing in IPO Boom Yahoo 01/24 23:44 ET
VCYT Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Veracyte is up N/A over the last year vs S&P 500 Total Return up 24.21%, Alexion Pharmaceuticals up 95.00%, and GlycoMimetics up N/A.
Balance Sheet View Statement
Pro Ratings for VCYT
Pro Strategies Featuring VCYT
Did Veracyte make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: United States
- Headquarters State/Province: California
- Incorporation Country: United States
- Incorporation State/Province: Delaware
Veracyte Inc is engaged in the discovery, development and commercialization of molecular cytology solutions that enable physicians to make more informed treatment decisions at an early stage in patient treatment.